Navigation Links
Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
Date:5/6/2009

WARSAW, Ind., May 6 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Bank of America and Merrill Lynch 2009 Healthcare Conference at the Palace Hotel in New York City on Wednesday, May 13, 2009 at 2:40 p.m. ET.

A live Web cast of the presentation will be available on Symmetry Medical's Web site at www.symmetrymedical.com. Presentation slides will be posted on the Web site before the presentation begins. A replay of the Web cast will be available for 60 days after the date of the presentation.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

    Investors/Media:                        Contact:
    The Ruth Group                          Symmetry Medical Inc.
    Nick Laudico/Jason Rando                Fred L. Hite
    (646) 536-7030/7025                     Senior Vice President
    nlaudico@theruthgroup.com               Chief Financial Officer
    jrando@theruthgroup.com                 (574) 371-2218


'/>"/>
SOURCE Symmetry Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
2. Symmetry Medical Launches New Global Web site
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
6. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Expand Malaysian Operations
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. Symmetry Medical Reports Full Year 2007 Financial Results
11. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...EAPOLIS, Dec. 3 The Ame...) has designated Hennepin Regional Poison Center i...ontrol center - a major milestone for the center. ...Regional Poison Center among 58 accredited poison ... represents a major accomplishment. It means we ha...
(Date:12/2/2009)...HINGTON, Dec. 2 In res... Supplement Safety Now ," an initiative from the...ations, the Council for Responsible Nutrition (CRN...dietary supplement industry, issued the following ...President and CEO: ,, "We share the concerns ...
(Date:12/2/2009)...t seen for advanced cases, study finds , ...st two decades, survival rates for advanced lung c...modestly, a new study has found. , Researchers ...sed with stage 4 non-small cell lung cancer (NSCLC...as in the U.S. National Cancer Institute,s Surveil...
(Date:12/2/2009)... prolongs life remains unclear, researchers say ,...New research suggests that enzyme replacement ther...ople with Fabry disease, a rare illness that affec...sive disease, linked to the lack of an enzyme that...n be fatal because it boosts the risk for a stroke...
(Date:12/2/2009)...E PLAINS, N.Y., Dec. 2 ...ir findings in blood cancer research at the annual...n New Orleans December 4-8, 2009. ,, Throughou...Society (LLS) experts, including Chief Medical Off...ent of Patient Services Hildy Dillon, and Vice Pre...
Breaking Medicine News(10 mins):Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Gains Made in Lung Cancer Survival 2
...ll discuss how to drive engagement on a global bas...ief Medical Officer Jim Reynolds, M.D., will speak...olutions Dialogue, set for Dec. 11 in Minneapolis...., , (Logo: http://www.newscom.com/cgi-bin/pr...
...(TM) brand just got,better with the addition of it...nd lattes. Each flavor contains Lifeguard(TM) Pro...ioxidant vitamins A, E and Zinc and has half the,c...said Chris New, founder, chairman and,CEO of NBI J...
... news service, along,with its production and distr... offering -- HealthDay TV -- designed to give view...h topics. , Each weekday starting in January...rtant, recent developments in medical,and health n...
... current and future community needs , , RIC...most viable healthcare systems are joining forces ... , Sentara Healthcare ( www.sentara.com ) and ...The agreement calls for each hospital system to op...
...eople, family gatherings, parties, and other socia...ason. Not so for those with social anxiety disorde...ports the December 2008 issue of Harvard Women,s ...are part of the fun of the holiday season. Not so ...
...irst 3 months more likely to have respiratory woes...nfants whose mothers take folic acid (folate) duri...respiratory illness, according to a Norwegian stud...a on more than 32,000 children born between 2000 a...
Other Medicine News:Health News:Driving Consumer Engagement Is Focus of Address by Healthfitness' Chief Medical Officer at Watson Wyatt Health Care Solutions Event 2Health News:New Sun Shower(TM) Super Blends: Iced Coffees, Teas, Lattes With Half the Calories 2Health News:HealthDay TV Launches 2Health News:HealthDay TV Launches 3Health News:Bon Secours, Sentara to Collaborate on Princess Anne Hospital 2Health News:Bon Secours, Sentara to Collaborate on Princess Anne Hospital 3Health News:Bon Secours, Sentara to Collaborate on Princess Anne Hospital 4Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2
(Date:12/3/2009)... , HELSINKI, December 3 /PRNewswire/ ...ly proven success in their field, Lightlake Therap... to begin selecting and gene testing,subjects for ...for what the,World Health Organisation has describ...esity. , A Phase II trial for the everyda...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlin...t is available in its catalogue: ,, EEG/EMG/B...,, http://www.reportlinker.com/p0164319/EEG/EM....html ,, Steep rise in obesity, cardiovascular...ectroencephalograph (EEG) diagnostic and monitorin...
(Date:12/2/2009)... ST. LOUIS, Dec. 2 KV Ph...at that it has entered into an employment agreemen...er David A. Van Vliet with a term through December...sident and Chief Executive Officer since December ...inuity of senior leadership as the Company seeks t...
Breaking Medicine Technology:Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2Helix BioPharma Corp Announces Fiscal 2009 Results 5849 1Helix BioPharma Corp Announces Fiscal 2009 Results 5849 2Helix BioPharma Corp Announces Fiscal 2009 Results 5849 3Helix BioPharma Corp Announces Fiscal 2009 Results 5849 4Helix BioPharma Corp Announces Fiscal 2009 Results 5849 5Helix BioPharma Corp Announces Fiscal 2009 Results 5849 6Helix BioPharma Corp Announces Fiscal 2009 Results 5849 7Helix BioPharma Corp Announces Fiscal 2009 Results 5849 8Helix BioPharma Corp Announces Fiscal 2009 Results 5849 9Helix BioPharma Corp Announces Fiscal 2009 Results 5849 10Helix BioPharma Corp Announces Fiscal 2009 Results 5849 11Helix BioPharma Corp Announces Fiscal 2009 Results 5849 12Helix BioPharma Corp Announces Fiscal 2009 Results 5849 13More Than 250 West Philadelphia Men Women and Children are Expected to Attend Wellness for Life Event 60355 1More Than 250 West Philadelphia Men Women and Children are Expected to Attend Wellness for Life Event 60355 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 1New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 2New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 3
... , , , , Company to Submit a Supplemental New D..., , FRAZER, Pa., April 6 Cephalon, Inc . (Nasda...a phase three clinical trial of NUVIGIL(R) (armoda... sleepiness associated with jet lag disorder. Bas...lemental New Drug Application with the U.S. Food a...
...SPRING, Md., April 2 Novo Nordisk today announced...ory Committee of the United States Food and Drug A...of questions related to liraglutide, a once-daily ... voted on questions related to the risk profile of...ory Committee members supported that appropriate e...
Other Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: